Literature DB >> 4722457

Studies on the mechanism of action of the tumour inhibitory triazenes.

R C Audette, T A Connors, H G Mandel, K Merai, W C Ross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4722457     DOI： 10.1016/0006-2952(73)90045-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  12 in total

1.  Combination chemotherapy.

Authors:  T A Connors
Journal:  Proc R Soc Med       Date:  1974-06

2.  [Carcinogenic activity of 13 aryldialkyl triazenes in BD-rats (author's transl)].

Authors:  R Preussmann; S Ivankovic; C Landschütz; J Gimmy; E Flohr; U Griesbach
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1974

3.  Metabolism and pharmacokinetics of p-(3,3-dimethyl-1-triazeno) benzoic acid in M5076 sarcoma-bearing mice.

Authors:  E Benfenati; P Farina; T Colombo; G De Bellis; M V Capodiferro; M D'Incalci
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Effects of an inducer and an inhibitor of hepatic metabolism on the antitumor action of dimethyltriazenes.

Authors:  G Sava; S Zorzet; L Perissin; T Giraldi; L Lassiani
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

5.  Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK.

Authors:  G Sava; S Zorzet; L Perissin; S Pacor; L Lassiani; C Nisi; A Varnavas
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

6.  Comparison of the antitumor activity of DTIC and 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on murine transplantable tumors and their hematological toxicity.

Authors:  T Colombo; M D'Incalci
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

Review 7.  N-methyl antitumour agents. A distinct class of anticancer drugs?

Authors:  D Newell; A Gescher; S Harland; D Ross; C Rutty
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

8.  Microsomal mediated metabolism of dialkylaryltriazenes. II. Isolation and identification of metabolites of 3,3-dimethyl-1-phenyltriazene.

Authors:  B L Pool
Journal:  J Cancer Res Clin Oncol       Date:  1979-04-12       Impact factor: 4.553

9.  Microsomal mediated metabolism of dialkylaryltriazenes. I. Demethylation of ring halogenated 3,3-dimethyl-1-phenyltriazenes.

Authors:  B L Pool
Journal:  J Cancer Res Clin Oncol       Date:  1979-04-12       Impact factor: 4.553

10.  DTIC xenogenized lines obtained from an L1210 clone: clonal analysis of cytotoxic T lymphocyte reactivity.

Authors:  O Marelli; P Franco; G Canti; L Ricci; N Prandoni; A Nicolin; H Festenstein
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.